HEARD (Long Term) Study - Histology of the Esophagus in Acid-Related Disease

• Status: Completed
• Trial end date: 2007-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Determine if different levels of acid-suppression with esomeprazole for 6 months on chosen histological markers of esophageal epithelial acid-related disease in patients with upper GI symptoms.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Esomeprazole

Criteria

Inclusion Criteria:

• Signed informed consent

• 18 years or older

• history of upper GI symptoms

Exclusion Criteria:

• Peptic ulcer disease

• upper gastrointestinal surgery

• malignancy